ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1016

Annual Cardiac or Orthopedic Procedure Volume in Gout versus Rheumatoid Arthritis: A National Time-trends Study

Jasvinder Singh1 and John Cleveland1, 1University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2020

Keywords: gout, Orthopedics, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The hospitalization rate for gout has been increasing in recent years with a reduction in people with RA. To our knowledge, there are no studies of time-trends in U.S. national estimates of cardiac versus orthopedic procedures in people with gout compared to RA. Our study objective was to compare time-trends in cardiac versus orthopedic procedures in people with gout versus RA. We hypothesized that (1) RA would be associated with higher annual volume and rates of both procedures at the beginning and the end of our study period, but the gout-RA gap will narrow over time, (2) increase in the annual volume of orthopedic procedures will be higher than cardiac procedures in both, and (3) increase in their annual volume in gout or RA will outpace that in the general U.S. population.

Methods: We examined the frequency of 7 common cardiac and orthopedic procedures in hospitalized people with gout or RA (or the general population) using the 1998-2014 U.S. National Inpatient Sample (NIS). Poisson regression evaluated the statistical significance of the differences in frequencies in 1998 versus 2014, between gout and RA, and within each cohort.

Results: The rate of cardiac procedures per 100,000 NIS claims decreased from 2,977 in 1998 to 2,292 in 2014; the rate of orthopedic procedures increased from 3,609 in 1998 to 6,160 in 2014 in the U.S. general population (Figure 1).

Both in-hospital cardiac and orthopedic procedures increased in gout and RA with time, in contrast to declining numbers in the general U.S. population; orthopedic procedures became more common than cardiac procedures in gout and RA. The corresponding increase in in-hospital cardiac and orthopedic procedure rates per 100,000 NIS claims in two populations were as follows: (1) gout, 2.3 (36.6 to 82.8) and 5.1-fold (34.2 to 174.6); and (2) RA, 1.6 (20.1 to 33.1) and 2.4-fold (70.2 to 170.8), respectively (Figure 2). In RA, the cardiac-orthopedic procedure volume difference was significant in 1998 and 2014. We noted no significant difference between cardiac versus orthopedic procedures in 1998 in gout, but the difference was significant in 2014. Cardiac procedures were significantly higher in gout versus RA in 1998 (59% higher) and 2014 (92% higher; Figure 2).

The orthopedic procedures in gout were significantly lower than RA in 1998 (33% lower), but were significantly higher than RA in 2014 (5% higher; Figure 2). Of all hospitalizations with cardiac/orthopedic procedures, the proportion of people with each as primary or secondary diagnosis increased from 1998 to 2014: (1) in-hospital cardiac procedures: 1.2% to 3.6% with gout; 0.7% to 1.4% with RA; and (2) in-hospital orthopedic procedures: 0.9% to 2.8% with gout; 1.9% to 2.8% with RA

Conclusion: Cardiac and orthopedic procedures increased in gout and RA 1998-2014 versus decline in the general population.  Cardiac procedure volumes and rates were higher in gout versus RA in 1998 and 2014. Increasing in-hospital cardiac procedures in gout and RA contrasting with declining rates in the general U.S. population indicated that early diagnosis of gout and RA, and management of systemic inflammation are needed. Orthopedic procedures were more in 1998, but fewer in 2014 in RA versus gout.

Figure 1. Time-trends in cardiac and orthopedic procedures in the U.S. general population during the study period 1998-2014 showing the overall trend (A), cardiac procedures by sex (B), orthopedic procedures by sex (C), cardiac procedures by age groups (D) and orthopedic procedures by age groups (E) Figure 1 legend: X-axis represents the study year and Y-axis shows the number of annual procedures. Estimates over time are shown with the line and the shaded area represents the upper and lower 95% confidence intervals. The Y-axis scales differs between panels.

Figure 2. Time-trends in cardiac and orthopedic procedures from 1998-2014 in people with gout or rheumatoid arthritis (RA) during the study period showing the overall trends Figure 2 legend: X-axis represents the study year and Y-axis shows the number of annual procedures. Estimates over time are shown with the line and the shaded area represents the upper and lower 95% confidence intervals. The Y-axis scales differs between panels.

Table 1. Rate per 100,000 NIS population hospitalization for cardiac or orthopedic procedures or all hospitalizations in people with a concomitant diagnosis of gout or rheumatoid arthritis (RA) from 1998 to 2014


Disclosure: J. Singh, Crealta/Horizon, 1, Medisys, 1, Fidia, 1, UBM LLC, 1, Trio health, 1, Medscape, 1, WebMD, 1, Clinical Care options, 1, Clearview healthcare partners, 1, Putnam associates, 1, Focus forward, 1, Navigant consulting, 1, Spherix, 1, Practice Point communications, 1, the National Institutes of Health, 1, the American College of Rheumatology, 1, Amarin pharmaceuticals, 1, Viking therapeutics, 1, OMERACT, 1; J. Cleveland, None.

To cite this abstract in AMA style:

Singh J, Cleveland J. Annual Cardiac or Orthopedic Procedure Volume in Gout versus Rheumatoid Arthritis: A National Time-trends Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/annual-cardiac-or-orthopedic-procedure-volume-in-gout-versus-rheumatoid-arthritis-a-national-time-trends-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/annual-cardiac-or-orthopedic-procedure-volume-in-gout-versus-rheumatoid-arthritis-a-national-time-trends-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology